PT91088A - Processo de preparacao de composicoes a base de alfa-,beta- ou gama- -cilcodextrinas - Google Patents

Processo de preparacao de composicoes a base de alfa-,beta- ou gama- -cilcodextrinas

Info

Publication number
PT91088A
PT91088A PT91088A PT9108889A PT91088A PT 91088 A PT91088 A PT 91088A PT 91088 A PT91088 A PT 91088A PT 9108889 A PT9108889 A PT 9108889A PT 91088 A PT91088 A PT 91088A
Authority
PT
Portugal
Prior art keywords
cells
virus
cyclodextrins
chemically modified
inhibiting
Prior art date
Application number
PT91088A
Other languages
English (en)
Other versions
PT91088B (pt
Inventor
Steven A Roth
Paul B Weisz
George Farnbach
David B Weiner
Mark I Greene
William V Williams
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of PT91088A publication Critical patent/PT91088A/pt
Publication of PT91088B publication Critical patent/PT91088B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT91088A 1988-07-07 1989-07-06 Processo de preparacao de composicoes a base de alfa-,beta- ou gama- -cilcodextrinas PT91088B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21617688A 1988-07-07 1988-07-07
US37300589A 1989-06-28 1989-06-28

Publications (2)

Publication Number Publication Date
PT91088A true PT91088A (pt) 1990-02-08
PT91088B PT91088B (pt) 1995-01-31

Family

ID=26910735

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91088A PT91088B (pt) 1988-07-07 1989-07-06 Processo de preparacao de composicoes a base de alfa-,beta- ou gama- -cilcodextrinas

Country Status (10)

Country Link
EP (1) EP0423240B1 (pt)
JP (1) JPH04500456A (pt)
KR (1) KR900702005A (pt)
AT (1) ATE129897T1 (pt)
AU (1) AU636850B2 (pt)
DE (1) DE68924774T2 (pt)
IE (1) IE75688B1 (pt)
PT (1) PT91088B (pt)
WO (1) WO1990000596A1 (pt)
ZA (1) ZA895187B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248675A (en) * 1990-03-15 1993-09-28 Tanabe Seiyaku Co., Ltd. Polysulfate of cyclodextrin derivative and process for preparing the same
DK0447171T3 (da) * 1990-03-15 1994-12-12 Tanabe Seiyaku Co Polysulfat af cyclodextrinderivat og fremgangsmåde til fremstilling deraf
GB9020872D0 (en) * 1990-09-25 1990-11-07 Ml Lab Plc Pharmaceutical compositions and use thereof
FR2669535A1 (fr) * 1990-11-26 1992-05-29 Medgenix Group Sa Utilisation a titre de medicament de macromolecules polysulfonees.
US5312837A (en) * 1991-01-29 1994-05-17 Genelabs Technologies, Inc. Method of treating viral infections with aryl macrocyclic compounds
JP2556236B2 (ja) * 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
WO1994003164A1 (en) * 1992-08-06 1994-02-17 Genelabs Technologies, Inc. Inhibition and treatment of infection by enveloped virus with calix(n) arene compounds
DE9316320U1 (de) * 1993-10-20 1994-01-20 Beni Med Natuerliche Heilmitte Kosmetische Zubereitung in Form von Lippenstiften mit antiviraler Wirkung
US5691316A (en) * 1994-06-01 1997-11-25 Hybridon, Inc. Cyclodextrin cellular delivery system for oligonucleotides
US6835717B2 (en) 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
DE10203999A1 (de) * 2002-02-01 2003-08-14 Nutricia Nv Cycloglycane
BR112021004081A2 (pt) 2018-09-04 2021-05-25 Ecole Polytechnique Federale De Lausanne (Epfl) nanopartículas virucidas, composição farmacêutica, composição virucida, método de desinfecção e/ou esterilização, dispositivo e uso das nanopartículas virucidas
BE1030002B1 (fr) 2021-12-29 2023-09-01 Aquilon Pharmaceuticals Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire
WO2023118014A1 (en) 2021-12-20 2023-06-29 Aquilon Pharmaceuticals Inhalable compositions comprising a complex of hpbcd and budesonide or ciclesonide for the treatment or prevention of a respiratory viral disease or lipopolysaccharide-induced inflammation, in particular lipopolysaccharide-induced inflammation associated with a respiratory viral disease
WO2024105648A1 (pt) 2022-11-17 2024-05-23 Silva Renata Moises Iwamizu Composição antiviral contendo compostos de inclusão com ciclodextrinas como moduladores de atividade e ativos antissépticos e seus usos
WO2024251923A1 (en) 2023-06-07 2024-12-12 Aquilon Pharmaceuticals Preservative-free compositions comprising a complex of a corticosteroid and hpbcd for the treatment or prevention of an inflammatory disease through nasal administration
BE1031693B1 (fr) 2023-06-07 2025-01-23 Aquilon Pharmaceuticals Compositions sans conservateur comprenant un complexe de corticostéroïde et d'hpbcd pour le traitement ou la prévention d'une maladie inflammatoire par administration nasale
BE1031691B1 (fr) 2023-06-07 2025-01-23 Aquilon Pharmaceuticals Compositions sans conservateur comprenant un complexe de corticostéroïde et d'hpbcd pour le traitement ou la prévention d'une maladie inflammatoire par administration nasale

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses

Also Published As

Publication number Publication date
PT91088B (pt) 1995-01-31
JPH04500456A (ja) 1992-01-30
KR900702005A (ko) 1990-12-05
AU4044389A (en) 1990-02-05
IE892183L (en) 1990-01-07
EP0423240A4 (en) 1992-07-22
WO1990000596A1 (en) 1990-01-25
DE68924774D1 (de) 1995-12-14
IE75688B1 (en) 1997-09-10
EP0423240B1 (en) 1995-11-08
AU636850B2 (en) 1993-05-13
ZA895187B (en) 1990-04-25
ATE129897T1 (de) 1995-11-15
EP0423240A1 (en) 1991-04-24
DE68924774T2 (de) 1996-05-02

Similar Documents

Publication Publication Date Title
PT91088A (pt) Processo de preparacao de composicoes a base de alfa-,beta- ou gama- -cilcodextrinas
BR0013771A (pt) Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
FI921609A7 (fi) Menetelmiä ja koostumuksia luun parantamiseksi
BR9913516A (pt) Processo para a produção de uma modificação em superfìcie que tem uma atividade não trombogênica melhorada, e, substrato modificado em superfìcie
DK0934310T3 (da) Thiosyreafledte, monocykliske forbindelser som antikoaguleringsmidler
PT91042A (pt) Processo de preparacao de derivados da pirimidina fundidos, dos seus intermediarios e de composicoes farmaceuticas
DE3785279D1 (de) Waesserige polysaccharid-zusammensetzungen.
HN2000000109A (es) Trifluorbutenos nematicidas
DE69023957D1 (de) Sulfatierte Polysaccharide, Antikoagulierungs- und Antikomplementärmittel, hergestellt aus Fukanen aus braunen Algen, und Verfahren zu deren Herstellung.
ATE87319T1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
BR9000873A (pt) Composicao desodorante e processo para tratar ou evitar maus cheiros associados a perspiracao de debaixo do braco de um ser humano
FI923402A0 (fi) Foerbaettrad cyklodextrinbaserad erytropoietinformulation.
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
DK0698018T3 (da) Inklusionskomplekser af Taxol eller Taxotere eller Taxus-ekstrakt dannet med cyclodextriner, deres fremstilling og anvendelse
FI945839A0 (fi) Bentsotiofeeniyhdisteiden ja vesiliukoisten syklodekstriinien inkluusiokompleksien vesipitoinen liuos ja niiden farmaseuttiset formulaatiot sekä menetelmä
PT94226A (pt) Processo de preparacao de 1,2-dioxetanos que produzem quimioluminescencia por activacao dupla
DE60022380D1 (de) Verwendung von einem trifluridin derivat allein oder in kombination mit einem thymidin-phosphorylase-hemmer zur behandlung von hiv
MX17877A (es) Composiciones antimalaria y metodos de tratamiento que utilizan quinidina, artemisinina y sus derivados.
KR970061246A (ko) 테스토스테론을 증가시키기 위한 약학 조성물
DK640587A (da) Cytostatisk virksomme anthracyclinderivater cytostatisk virksomme anthracyclinderivater
ES2088414T3 (es) Composiciones agricolas de espuma.
DE69003075D1 (de) Stabilisierungszusammensetzungen.
DE69008368D1 (de) Verfahren zur Herstellung von (+)-(2S,3S)-3-hydroxy-2-(4-methoxy-phenyl)-2,3-dihydro-5H-1,5-benzothiazepin-4-on-Derivaten.
IT1318432B1 (it) Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
AR009105A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940712

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19980131